Filing Details
- Accession Number:
- 0001144204-11-049272
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-23 08:39:12
- Reporting Period:
- 2011-08-19
- Filing Date:
- 2011-08-23
- Accepted Time:
- 2011-08-23 08:39:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 811641 | Immucell Corp | ICCC | In Vitro & In Vivo Diagnostic Substances (2835) | 010382980 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1384044 | Scott David Tomsche | C/O Immucell Corporation 56 Evergreen Drive Portland ME US 04103 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.10 Per Share | Acquisiton | 2011-08-19 | 15,000 | $5.80 | 52,668 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Options (Right to Buy) | Disposition | 2011-08-19 | 15,000 | $0.00 | 15,000 | $5.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-12-20 | No | 4 | X | Direct |
Footnotes
- Exercisable as to 5,000 shares on and after June 8, 2007 and an additional 5,000 shares on and after June 7, 2008 and the remaining 5,000 shares on and after June 13, 2009.
Billionaire Hedge Funds
